DK94619C - Fremgangsmåde til fremstilling af spiro-(piperidyl-4)-succinimidforbindelser. - Google Patents

Fremgangsmåde til fremstilling af spiro-(piperidyl-4)-succinimidforbindelser.

Info

Publication number
DK94619C
DK94619C DK113860AA DK113860A DK94619C DK 94619 C DK94619 C DK 94619C DK 113860A A DK113860A A DK 113860AA DK 113860 A DK113860 A DK 113860A DK 94619 C DK94619 C DK 94619C
Authority
DK
Denmark
Prior art keywords
piperidyl
spiro
preparation
succinimide compounds
succinimide
Prior art date
Application number
DK113860AA
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of DK94619C publication Critical patent/DK94619C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
DK113860AA 1959-03-25 1960-03-24 Fremgangsmåde til fremstilling af spiro-(piperidyl-4)-succinimidforbindelser. DK94619C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7124959A CH375356A (de) 1959-03-25 1959-03-25 Verfahren zur Herstellung von neuen substituierten Succinimiden

Publications (1)

Publication Number Publication Date
DK94619C true DK94619C (da) 1962-10-29

Family

ID=4530864

Family Applications (1)

Application Number Title Priority Date Filing Date
DK113860AA DK94619C (da) 1959-03-25 1960-03-24 Fremgangsmåde til fremstilling af spiro-(piperidyl-4)-succinimidforbindelser.

Country Status (4)

Country Link
US (1) US3056796A (da)
AT (1) AT215992B (da)
CH (1) CH375356A (da)
DK (1) DK94619C (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518275A (en) * 1964-03-24 1970-06-30 Sandoz Ag 8-carbobenzoxy-1,3,8-triazaspiro(4,5)decane-2,4-dione
BE897058A (fr) * 1982-06-25 1983-12-16 Sandoz Sa Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer
US9017724B2 (en) 2004-02-24 2015-04-28 The General Hospital Corporation Catalytic radiofluorination
US8257680B1 (en) 2004-02-24 2012-09-04 The General Hospital Corporation Catalytic radiofluorination
US20080247964A1 (en) * 2006-05-08 2008-10-09 Yuelian Xu Substituted azaspiro derivatives
EP3231804B1 (en) 2008-03-21 2021-03-03 The General Hospital Corporation Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders
CA2996717A1 (en) 2015-09-11 2017-03-16 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB592016A (en) * 1945-02-07 1947-09-04 Wellcome Found Improvements relating to the synthesis of derivatives of piperidine
US2978454A (en) * 1955-09-12 1961-04-04 Sterling Drug Inc Lower alkyl-4-phenyl-1-[(diloweralkoxy phenyl)-aliphatic] piperidine-4-carboxylates

Also Published As

Publication number Publication date
AT215992B (de) 1961-07-10
US3056796A (en) 1962-10-02
CH375356A (de) 1964-02-29

Similar Documents

Publication Publication Date Title
DK94619C (da) Fremgangsmåde til fremstilling af spiro-(piperidyl-4)-succinimidforbindelser.
DK119710B (da) Fremgangsmåde til fremstilling af polyozoaluminiumforbindelser.
DK110017C (da) Fremgangsmåde til fremstilling af organiske aluminiumforbindelser.
DK104677C (da) Fremgangsmåde til fremstilling af 3-halogen-iminodibenzylforbindelser.
DK107164C (da) Fremgangsmåde til fremstilling af 18-acyloxy- eller 18-hydroxy-pregnan-forbindelser.
DK108728C (da) Fremgangsmåde til fremstilling af disulfamylanilinforbindelser.
DK101857C (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-alkoksypyrimidinforbindelser.
DK94783C (da) Fremgangsmåde til fremstilling af 4-nitro-pyrazolforbindelser.
DK94943C (da) Fremgangsmåde til fremstilling af 4-nitro-pyrazolforbindelser.
DK95945C (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-alkoksypyrimidinforbindelser.
DK101182C (da) Fremgangsmåde til fremstilling af 7-hydroxy-chromon-forbindelser.
DK102676C (da) Fremgangsmåde til fremstilling af phenylethyl-decalin- eller -hexahydroindanforbindelser.
DK97878C (da) Fremgangsmåde til fremstilling af 16-methylen-17&aplha;-hydroxy-20-ketopregnenforbindelser.
DK94620C (da) Fremgangsmåde til fremstilling af N-heterocycliske forbindelser.
DK94674C (da) Fremgangsmåde til fremstilling af N-heterocycliske forbindelser.
DK101916C (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-methoxy- eller ethoxy-pyrimidinforbindelser.
DK92023C (da) Fremgangsmåde til fremstilling af β-aminoalkylthianaphthen- eller β-aminoalkylbenzofuran-forbindelser.
DK94409C (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-methoxy- eller ethoxypyrimidinforbindelser.
DK102677C (da) Fremgangsmåde til fremstilling af phenylethyl-octalin- eller -tetrahydroindanforbindelser.
DK95414C (da) Fremgangsmåde til fremstilling af 9α-fluor-11β-hydroxy- eller 11-oxo-16α-methylprogesteron-forbindelser.
DK94625C (da) Fremgangsmåde til fremstilling af heterocycliske o-quinonforbindelser.
DK115180B (da) Analogifremgangsmåde til fremstilling af 1-dehydro-16-methylen-17α-acetoxy-progesteronforbindelser.
DK93950C (da) Fremgangsmåde til fremstilling af substituerede pyrrolidinoler.
DK100292C (da) Fremgangsmåde til fremstilling af 4-hydroxy-3-keto-4-androstenforbindelser.
DK104514C (da) Fremgangsmåde til fremstilling af 3-nitro-5-acyl-iminodibenzylforbindelser.